Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug-eluting stents succeed after bare metal stents fail

12.09.2005


Accurate stent positioning does not require use of high-tech device

Once a coronary stent becomes blocked with scar tissue, the likelihood it will become blocked again is 30 percent to 80 percent. Inserting a second coronary stent that slowly releases anti-scarring medication can markedly cut that risk, according to a study in the just-published October 2005 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.

Researchers also showed that it was unnecessary to thread a high-tech ultrasound device into the artery to guide precise placement of the drug-eluting stent. Instead, they reduced the risk of blood clotting by minimizing trauma to the artery--no stretching of the artery before or after the procedure, for example--and prescribing a double dose of anti-clotting drugs for two months.



"Our slogan is not ’Bigger is better,’ but ’A nice, quick job is better,’" said Dr. Philippe Commeau, of Centre Hospitalier Prive Beauregard in Marseille, France.

Twenty-three patients participated in the ISR II study. All had in-stent restenosis (ISR), an overgrowth of scar tissue inside a bare metal stent. They also had chest pain and some other sign that too little blood was flowing to the heart.

Patients were treated by insertion of a Cypher stent (Cordis Corp., Miami) on top of the original bare metal stent. The Cypher stent slowly releases sirolimus into the artery wall, a medication that prevent the overgrowth of the tissue that causes in-stent restenosis. Interventional cardiologists used standard x-ray angiography to determine the correct placement of the stent.

During two years of follow-up, four patients (17 percent) had yet another procedure to open the stented artery. Two of the patients had no chest pain and showed no evidence of a shortfall of blood flow to the heart. Therefore, the study’s authors pegged the true clinical restenosis rate at only 8.5 percent.

Since the conclusion of the ISR II study, Dr. Commeau and his colleagues have followed the progress of 200 similar patients for more than two years. They expect to publish the results of that study soon.

Kathy Boyd David | EurekAlert!
Further information:
http://www.scai.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>